- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Mediators of Inflammation Volume 2013, Article ID 716902, 7 pages http://dx.doi.org/10.1155/2013/716902
- Schlagwort
-
Kardiovaskuläre Krankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2016
- Urheber
- URN
-
urn:nbn:de:bvb:20-opus-129668
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Frey, A.
- Ertl, G.
- Angermann, Christiane
- Hofmann, U.
- Störk, S.
- Frantz, S.
- Universität Würzburg
Entstanden
- 2016
Ähnliche Objekte (12)
How can we cure a heart "in flame"? A translational view on inflammation in heart failure
The Biomarker Armamentarium for Heart Failure
When fat meets the engine: implications of dietary rumenic acid on myosin-targeting therapies in heart failure
Differential influences of complement on neutrophil responses to \(Neisseria\) \(meningitidis\) infection
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Fractal Correlation Properties of Heart Rate Variability: A New Biomarker for Intensity Distribution in Endurance Exercise and Training Prescription?
Putative Biomarker neuropsychiatrischer Entwicklungskomorbiditäten beim Deletionssyndrom 22q11.2
Serum fibroblast growth factor-2 levels complement vital biomarkers for diagnosing heart failure
Evaluierung prognostischer und prädiktiver Biomarker beim neoadjuvant vorbehandelten Rektumkarzinom
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
Biomarker profiling for risk of future heart failure (HFpEF) development
How can we cure a heart "in flame"? A translational view on inflammation in heart failure
The Biomarker Armamentarium for Heart Failure
When fat meets the engine: implications of dietary rumenic acid on myosin-targeting therapies in heart failure
Differential influences of complement on neutrophil responses to \(Neisseria\) \(meningitidis\) infection
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Fractal Correlation Properties of Heart Rate Variability: A New Biomarker for Intensity Distribution in Endurance Exercise and Training Prescription?
Putative Biomarker neuropsychiatrischer Entwicklungskomorbiditäten beim Deletionssyndrom 22q11.2
Serum fibroblast growth factor-2 levels complement vital biomarkers for diagnosing heart failure
Evaluierung prognostischer und prädiktiver Biomarker beim neoadjuvant vorbehandelten Rektumkarzinom
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
Biomarker profiling for risk of future heart failure (HFpEF) development
How can we cure a heart "in flame"? A translational view on inflammation in heart failure
The Biomarker Armamentarium for Heart Failure
When fat meets the engine: implications of dietary rumenic acid on myosin-targeting therapies in heart failure
Differential influences of complement on neutrophil responses to \(Neisseria\) \(meningitidis\) infection
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Fractal Correlation Properties of Heart Rate Variability: A New Biomarker for Intensity Distribution in Endurance Exercise and Training Prescription?
Putative Biomarker neuropsychiatrischer Entwicklungskomorbiditäten beim Deletionssyndrom 22q11.2
Serum fibroblast growth factor-2 levels complement vital biomarkers for diagnosing heart failure
Evaluierung prognostischer und prädiktiver Biomarker beim neoadjuvant vorbehandelten Rektumkarzinom
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?